Allarity Therapeutics Other 8-K Filing
Allarity Therapeutics has been granted Japanese Patent No. 7917283 by the Japan Patent Office, covering its proprietary stenoparib-specific Drug Response Predictor (DRP) companion diagnostic. The patent provides intellectual property protection in Japan through 2039 for methods of predicting clinical benefit and selecting patients for stenoparib treatment. This follows similar patent protections already secured in the United States, Europe, and Australia.
- Counterparty
- Japan Patent Office
- Term
- through 2039